Bianchini LF, Arruda MF, Vieira SR et al (2015) Microbial biotransformation to obtain new
antifungals. Front Microbiol 6:1433
Buhler DR, Williams DE (1988) The role of biotransformation in the toxicity of chemicals. Aquat
Toxicol 11(1–2):19–28
David JP, Peter GF, Miners JO (2005) “Phase I and phase II” drug metabolism: terminology that we
should phase out? Drug Metab Rev 37(4):575–580
Doelle HW, Rokem JS, Berovic M (2009) Biotechnology: fundamentals in biotechnology. EOLSS
Publications, Oxford, p 10
Döring B, Petzinger E (2014) Phase 0 and phase III transport in various organs: combined concept
of phases in xenobiotic transport and metabolism. Drug Metab Rev 46(3):261–282
Fan LL, Li HJ, Chen QH (2014) Applications and mechanisms of ionic liquids in whole-cell
biotransformation. Int J Mol Sci 5(7):12196–12216
Gao F, Zhang JM, Wang ZG et al (2013) Biotransformation, a promising technology for anti-cancer
drug development. Asian Pac J Cancer Prev 14(10):5599–5608
Gaynes BI, Fiscella RG (1996) Biotransformation in review: applications in ocular disease and drug
design. J Ocul Pharmacol Ther 12(4):527–539
Hacker M, Messer WS, Bachmann KA (2009) Pharmacology: principles and practice. Academic
Press, Amsterdam
Hansen TWR, Bratlid D (1986) Bilirubin and brain toxicity. Acta Paediatr 75(4):513–522
Hediger MA, Romero MF, Peng JB, Rolfs A, Takanaga H, Bruford EA (2004) The ABCs of solute
carriers: physiological, pathological and therapeutic implications of human membrane transport
proteins. Pflugers Arch 447(5):465–468
Hediger MA, Clémençon B, Burrier RE, Bruford EA (2013) The ABCs of membrane transporters in
health and disease (SLC series): introduction. Mol Aspects Med 34(2–3):95–107
Hellstén S (2013) Recovery of biomass-derived valuable compounds using chromatographic and
membrane separations. Acta Universitatis Lappeenrantaensis, Tampere
Ishikawa T (1992) The ATP-dependent glutathione S-conjugate export pump. Trends Biochem Sci
17(11):463–468
Jancova P, Anzenbacher P, Anzenbacherova E et al (2010) Phase II drug metabolizing enzymes.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 154(2):103–116
Kebamo S, Tesema S, Geleta B (2015) The role of biotransformation in drug discovery and
development. J Drug Metab Toxicol 6(196):2
Kuntz E (2008) Hepatology: textbook and atlas. Springer, Berlin, p 38
Lech JJ, Vodicnik MJ (1985) Biotransformation. In: Fundamentals of aquatic toxicology: methods
and applications. Hemisphere Publishing Corporation, Washington, pp 526–557
Lilly MD (1992) The design and operation of biotransformation processes. In: Vardar-Sukan F,
Sukan ŞS (eds) Recent advances in biotechnology, vol 210. Kluwer, Dordrecht, pp 47–68
Lin B, Tao Y (2017) Whole-cell biocatalysts by design. Microb Cell Fact 16(1):106
Liska DJ (1998) The detoxification enzyme systems. Altern Med Rev 3(3):187–198
McDonald AG, Boyce S, Tipton KF (2001) Enzyme classification and nomenclature. eLS 83:289–
300
Pang KS, Kwan KC (1983) A commentary: methods and assumptions in the kinetic estimation of
metabolite formation. Drug Metab Dispos 11(2):79–84
Parkinson A (2001) Biotransformation of xenobiotics. McGraw-Hill, New York
Peeples TL (2014) Bioremediation using extremophiles. In: Microbial biodegradation and bioremediation. Elsevier, Amsterdam, pp 251–268
Pelikan EW (2004) Glossary of terms and symbols used in pharmacology. University School of
Medicine, Department of Pharmacology and Experimental Therapeutics, Boston
Petzinger E, Geyer J (2006) Drug transporters in pharmacokinetics. Naunyn Schmiedebergs Arch
Pharmacol 372(6):465–475
Ren Q, Paulsen IT (2005) Comparative analyses of fundamental differences in membrane transport
capabilities in prokaryotes and eukaryotes. PLoS Comput Biol 1(3):e27
Renton KW (1986) Factors affecting drug biotransformation. Clin Biochem 19(2):72–75
356
M. H. Yashavarddhan et al.
antifungals. Front Microbiol 6:1433
Buhler DR, Williams DE (1988) The role of biotransformation in the toxicity of chemicals. Aquat
Toxicol 11(1–2):19–28
David JP, Peter GF, Miners JO (2005) “Phase I and phase II” drug metabolism: terminology that we
should phase out? Drug Metab Rev 37(4):575–580
Doelle HW, Rokem JS, Berovic M (2009) Biotechnology: fundamentals in biotechnology. EOLSS
Publications, Oxford, p 10
Döring B, Petzinger E (2014) Phase 0 and phase III transport in various organs: combined concept
of phases in xenobiotic transport and metabolism. Drug Metab Rev 46(3):261–282
Fan LL, Li HJ, Chen QH (2014) Applications and mechanisms of ionic liquids in whole-cell
biotransformation. Int J Mol Sci 5(7):12196–12216
Gao F, Zhang JM, Wang ZG et al (2013) Biotransformation, a promising technology for anti-cancer
drug development. Asian Pac J Cancer Prev 14(10):5599–5608
Gaynes BI, Fiscella RG (1996) Biotransformation in review: applications in ocular disease and drug
design. J Ocul Pharmacol Ther 12(4):527–539
Hacker M, Messer WS, Bachmann KA (2009) Pharmacology: principles and practice. Academic
Press, Amsterdam
Hansen TWR, Bratlid D (1986) Bilirubin and brain toxicity. Acta Paediatr 75(4):513–522
Hediger MA, Romero MF, Peng JB, Rolfs A, Takanaga H, Bruford EA (2004) The ABCs of solute
carriers: physiological, pathological and therapeutic implications of human membrane transport
proteins. Pflugers Arch 447(5):465–468
Hediger MA, Clémençon B, Burrier RE, Bruford EA (2013) The ABCs of membrane transporters in
health and disease (SLC series): introduction. Mol Aspects Med 34(2–3):95–107
Hellstén S (2013) Recovery of biomass-derived valuable compounds using chromatographic and
membrane separations. Acta Universitatis Lappeenrantaensis, Tampere
Ishikawa T (1992) The ATP-dependent glutathione S-conjugate export pump. Trends Biochem Sci
17(11):463–468
Jancova P, Anzenbacher P, Anzenbacherova E et al (2010) Phase II drug metabolizing enzymes.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 154(2):103–116
Kebamo S, Tesema S, Geleta B (2015) The role of biotransformation in drug discovery and
development. J Drug Metab Toxicol 6(196):2
Kuntz E (2008) Hepatology: textbook and atlas. Springer, Berlin, p 38
Lech JJ, Vodicnik MJ (1985) Biotransformation. In: Fundamentals of aquatic toxicology: methods
and applications. Hemisphere Publishing Corporation, Washington, pp 526–557
Lilly MD (1992) The design and operation of biotransformation processes. In: Vardar-Sukan F,
Sukan ŞS (eds) Recent advances in biotechnology, vol 210. Kluwer, Dordrecht, pp 47–68
Lin B, Tao Y (2017) Whole-cell biocatalysts by design. Microb Cell Fact 16(1):106
Liska DJ (1998) The detoxification enzyme systems. Altern Med Rev 3(3):187–198
McDonald AG, Boyce S, Tipton KF (2001) Enzyme classification and nomenclature. eLS 83:289–
300
Pang KS, Kwan KC (1983) A commentary: methods and assumptions in the kinetic estimation of
metabolite formation. Drug Metab Dispos 11(2):79–84
Parkinson A (2001) Biotransformation of xenobiotics. McGraw-Hill, New York
Peeples TL (2014) Bioremediation using extremophiles. In: Microbial biodegradation and bioremediation. Elsevier, Amsterdam, pp 251–268
Pelikan EW (2004) Glossary of terms and symbols used in pharmacology. University School of
Medicine, Department of Pharmacology and Experimental Therapeutics, Boston
Petzinger E, Geyer J (2006) Drug transporters in pharmacokinetics. Naunyn Schmiedebergs Arch
Pharmacol 372(6):465–475
Ren Q, Paulsen IT (2005) Comparative analyses of fundamental differences in membrane transport
capabilities in prokaryotes and eukaryotes. PLoS Comput Biol 1(3):e27
Renton KW (1986) Factors affecting drug biotransformation. Clin Biochem 19(2):72–75
356
M. H. Yashavarddhan et al.